Effect of camel milk protein hydrolysates against hyperglycemia, hyperlipidemia, and associated oxidative stress in streptozotocin (STZ)-induced diabetic rats

• Published in: Journal of dairy science Vol. 104; no. 2; pp. 1304 - 1317
• Main Authors: Kilari, Bhanu Priya, Mudgil, Priti, Azimullah, Sheikh, Bansal, Nidhi, Ojha, Shreesh, Maqsood, Sajid
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.02.2021
• Subjects: Animals; Antioxidants - therapeutic use; Blood Glucose - analysis; camel milk; Camelus - metabolism; diabetes mellitus; Diabetes Mellitus, Experimental - blood; Diabetes Mellitus, Experimental - drug therapy; Diabetes Mellitus, Experimental - pathology; hypoglycemia; Hypoglycemic Agents - therapeutic use; Hypolipidemic Agents - therapeutic use; Insulin-Secreting Cells - pathology; Lipid Peroxidation - drug effects; Liver - chemistry; Liver - pathology; Male; Malondialdehyde - metabolism; Milk - metabolism; Milk Proteins - therapeutic use; Oxidative Stress - drug effects; protein hydrolysates; Protein Hydrolysates - therapeutic use; Rats; streptozotocin; protein hydrolysates; diabetes mellitus; streptozotocin; camel milk; hypoglycemia

This study investigated the effect of camel milk protein hydrolysates (CMPH) at 100, 500 and 1,000 mg/kg of body weight (BW) for 8 wk on hyperglycemia, hyperlipidemia, and associated oxidative stress in streptozotocin-induced diabetic rats. Body weights and fasting blood glucose levels were observed...